JP2011506917A5 - - Google Patents

Download PDF

Info

Publication number
JP2011506917A5
JP2011506917A5 JP2010536378A JP2010536378A JP2011506917A5 JP 2011506917 A5 JP2011506917 A5 JP 2011506917A5 JP 2010536378 A JP2010536378 A JP 2010536378A JP 2010536378 A JP2010536378 A JP 2010536378A JP 2011506917 A5 JP2011506917 A5 JP 2011506917A5
Authority
JP
Japan
Prior art keywords
seprase
crc
detection
measurement results
ferritin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010536378A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011506917A (ja
JP5591711B2 (ja
Filing date
Publication date
Priority claimed from EP07023897A external-priority patent/EP2071337A1/en
Application filed filed Critical
Priority claimed from PCT/EP2008/010386 external-priority patent/WO2009074276A2/en
Publication of JP2011506917A publication Critical patent/JP2011506917A/ja
Publication of JP2011506917A5 publication Critical patent/JP2011506917A5/ja
Application granted granted Critical
Publication of JP5591711B2 publication Critical patent/JP5591711B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010536378A 2007-12-10 2008-12-08 結腸直腸癌のためのマーカーパネル Expired - Fee Related JP5591711B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP07023897.7 2007-12-10
EP07023897A EP2071337A1 (en) 2007-12-10 2007-12-10 Seprase as a marker for cancer
EP08017119 2008-09-29
EP08017119.2 2008-09-29
PCT/EP2008/010386 WO2009074276A2 (en) 2007-12-10 2008-12-08 Marker panel for colorectal cancer

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014155200A Division JP2014211452A (ja) 2007-12-10 2014-07-30 結腸直腸癌のためのマーカーパネル

Publications (3)

Publication Number Publication Date
JP2011506917A JP2011506917A (ja) 2011-03-03
JP2011506917A5 true JP2011506917A5 (https=) 2011-10-06
JP5591711B2 JP5591711B2 (ja) 2014-09-17

Family

ID=40344417

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2010536378A Expired - Fee Related JP5591711B2 (ja) 2007-12-10 2008-12-08 結腸直腸癌のためのマーカーパネル
JP2014155200A Pending JP2014211452A (ja) 2007-12-10 2014-07-30 結腸直腸癌のためのマーカーパネル

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014155200A Pending JP2014211452A (ja) 2007-12-10 2014-07-30 結腸直腸癌のためのマーカーパネル

Country Status (7)

Country Link
US (1) US20100240068A1 (https=)
EP (1) EP2223116B1 (https=)
JP (2) JP5591711B2 (https=)
CN (1) CN101896817A (https=)
CA (1) CA2701970A1 (https=)
ES (1) ES2527649T3 (https=)
WO (1) WO2009074276A2 (https=)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108181457B (zh) 2009-03-12 2021-03-30 癌症预防和治疗有限公司 鉴定、评估、预防以及治疗肺疾病的方法及试剂盒
AU2010264067A1 (en) * 2009-06-23 2012-01-19 Eventus Diagnostics Israel Ltd. A method and system for the detection of cancer
EP2426615A1 (en) 2010-08-06 2012-03-07 Roche Diagnostics GmbH Evaluation device for assisting in the assessment of colorectal cancer
WO2012047899A2 (en) * 2010-10-04 2012-04-12 The Johns Hopkins University Novel dna hypermethylation diagnostic biomarkers for colorectal cancer
EP2463659A1 (en) * 2010-12-13 2012-06-13 Université de Liège Biomarkers for cancer diagnosis
JP2014509736A (ja) * 2011-03-11 2014-04-21 エフ.ホフマン−ラ ロシュ アーゲー 慢性閉塞性肺疾患(copd)のマーカーとしてのセプラーゼ
CN102183662A (zh) * 2011-03-22 2011-09-14 浙江大学 一种大肠癌预后预测模型的建立方法
AU2012249288C1 (en) * 2011-04-29 2017-12-21 Lung Cancer Proteomics Llc Methods of identification and diagnosis of lung diseases using classification systems and kits thereof
SG11201504241QA (en) * 2012-11-30 2015-06-29 Applied Proteomics Inc Method for evaluation of presence of or risk of colon tumors
EP2916134B1 (en) 2014-03-05 2017-08-16 Roche Diagnostics GmbH Use of Seprase for differential diagnosis of acute dyspnea
EP3183578B8 (en) * 2014-08-22 2020-07-15 Abbott Laboratories Methods for the early detection of colorectal cancer
WO2016164815A1 (en) 2015-04-10 2016-10-13 Applied Proteomics, Inc. Protein biomarker panels for detecting colorectal cancer and advanced adenoma
BR112018017336A2 (pt) 2016-03-07 2018-12-26 Hoffmann La Roche método in vitro para detectar um anticorpo para p53 (anticorpo anti-p53) em uma amostra e polipeptídeo de fusão
CN110709936A (zh) 2017-04-04 2020-01-17 肺癌蛋白质组学有限责任公司 用于早期肺癌预后的基于血浆的蛋白质概况分析
AU2019252672B2 (en) 2018-04-12 2025-08-14 Board Of Regents, The University Of Texas System Biomarker for detecting cancer
ES2952139T3 (es) * 2019-03-01 2023-10-27 Advanced Marker Discovery S L Firma proteica para el diagnóstico de cáncer colorrectal y/o etapa precancerosa del mismo
CN109902411B (zh) * 2019-03-07 2020-08-11 三峡大学 土壤重金属含量检测建模方法及装置、检测方法及装置
WO2021024009A1 (en) * 2019-08-02 2021-02-11 Shanghai Yunxiang Medical Technology Co., Ltd. Methods and compositions for providing colon cancer assessment using protein biomarkers
EP4041888A4 (en) 2019-10-11 2023-11-01 Guardant Health, Inc. USE OF CELLULAR BACTERIAL NUCLEIC ACIDS FOR CANCER DETECTION
WO2023282916A1 (en) 2021-07-09 2023-01-12 Guardant Health, Inc. Methods of detecting genomic rearrangements using cell free nucleic acids
EP4179111B1 (en) 2020-07-10 2024-04-03 Guardant Health, Inc. Methods of detecting genomic rearrangements using cell free nucleic acids
CN112951332A (zh) * 2021-02-25 2021-06-11 北京博富瑞基因诊断技术有限公司 一种基于aGVHD biomarker的重度肠道aGVHD模型的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5455160A (en) * 1993-05-27 1995-10-03 Fagerhol; Magne K. Diagnostic test and kit for disease or disorders in the digestive system
US5695761A (en) * 1993-12-23 1997-12-09 Rutgers University Suppression of nitric oxide production by osteopontin
EP0953639A1 (en) * 1998-04-30 1999-11-03 Boehringer Ingelheim International GmbH FAPalpha-specific antibody with improved producibility
US6414219B1 (en) * 1998-06-30 2002-07-02 Rutgers, The State University Of New Jersey Osteopontin knock-out mouse and methods of use thereof
AU8843701A (en) * 2000-09-09 2002-03-22 Univ New York State Res Found Method and compositions for isolating metastatic cancer cells, and use in measuring metastatic potential of a cancer thereof
DE602005014386D1 (de) * 2004-12-23 2009-06-18 Roche Diagnostics Gmbh Verwendung von cyfra 21-1 und osteopontin als marker für kolorektalkarzinome
US7399869B2 (en) * 2005-05-19 2008-07-15 Genentech, Inc. Fibroblast activation protein inhibitor compounds and methods
CA2632327A1 (en) * 2005-12-22 2007-06-28 F. Hoffmann-La Roche Ag Use of a marker combination comprising osteopontin and carcinoembryonic antigen in the assessment of colorectal cancer
EP1994415B9 (en) * 2006-03-13 2015-12-16 Becton Dickinson and Company Diagnosis and prognosis of dipeptidyl peptidase-associated disease states

Similar Documents

Publication Publication Date Title
JP2011506917A5 (https=)
Zhong et al. Toward rapid and sensitive detection of SARS-CoV-2 with functionalized magnetic nanoparticles
Hwang et al. High sensitive and selective electrochemical biosensor: Label-free detection of human norovirus using affinity peptide as molecular binder
WO2009074276A3 (en) Marker panel for colorectal cancer
ATE538386T1 (de) Nachweis von krebs anhand von erhöhten bcl-2- konzentrationen
JP2009538607A5 (https=)
ATE425266T1 (de) Aptamer-nanopartikelkonjugate und verwendungsverfahren zur detektion von zielanalyten
Haji-Hashemi et al. Simple and effective label free electrochemical immunosensor for Fig mosaic virus detection
JP2018535404A5 (https=)
JP2012507033A5 (https=)
WO2010033371A3 (en) Molecular markers for lung and colorectal carcinomas
WO2013093635A3 (en) Plasma micrornas for the detection of early colorectal cancer
BRPI1007867B8 (pt) anticorpo recombinante ou fragmento de ligação ao antígeno do mesmo, composição farmacêutica e kit compreendendo o referido anticorpo, métodos de detecção de antígeno de troponina i em uma amostra de teste e métodos in vitro de diagnóstico de síndrome coronariana aguda ou infarto do miocárdio em um paciente
JP2014533372A5 (https=)
JP2008529008A5 (https=)
Beretov et al. Proteomics for breast cancer urine biomarkers
JP2012073260A5 (https=)
WO2010051544A3 (en) Rapid homogeneous diagnostic testing platform based on lanthanide fluorescent resonance energy transfer
JP2009539082A5 (https=)
DE60129151D1 (de) Verfahren zur erkennung von eierstockkrebs mittels menschlichem kallikrein (hk6)
WO2008109075A3 (en) Biomarkers and methods for determining sensitivity to ctla-4 antagonists
CA2701341A1 (en) Method of assessing colorectal cancer from a stool sample by use of the marker combination calprotectin and hemoglobin/haptoglobin complex
EP2619587A4 (en) BIOMARKER FOR PREDICTING THE REPRODUCTION OF A COLORECTAL CARCINOMA
WO2012159072A3 (en) Fluorescent molecular probes for use in assays that measure test compound competitive binding with sam-utilizing proteins
WO2015077382A3 (en) Combined cytology and molecular testing for early detection of esophageal adenocarcinoma